Spinal Tech

Simplify Medical concluded enrollment for its U.S. investigational device exemption trial testing the Simplify cervical artificial disc.

Enrollment is completed for Spineology's SCOUT clinical trial.

After crossing the 95 percent threshold in Vexim, Stryker plans to file a public buy-out offer followed by a squeeze-out for outstanding Vexim shares.

Here are 16 key notes on orthopedic and spine device companies from the past week.

Mazor Robotics reported full year 2017 revenue at $64.9 million, including its investment from Medtronic for Mazor X systems. Mazor has now invested around $72 million in Mazor and taken over marketing efforts for the product; the companies will develop…

Stryker named Kevin Lobo CEO in October 2012. Here are five things to know about him:

Vik Kapoor, MD, a Medovex medical advisory board member, presented initial data from his DenerveX System study.

Enrollment started for a study testing Orthofix's RCStim device as an adjunctive treatment to surgically mending full thickness rotator cuff tears.

Medtronic hired Gregory Zimprich to serve as the director of finance communications, according to PR Week.

Surgeons performed the first procedures using Camber Spine's SPIRA-C Open Matrix Cervical Interbody device.